These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics. Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122 [TBL] [Abstract][Full Text] [Related]
5. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671 [TBL] [Abstract][Full Text] [Related]
6. The effects of clozapine and risperidone on spatial working memory in schizophrenia. McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811 [TBL] [Abstract][Full Text] [Related]
7. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone. Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513 [TBL] [Abstract][Full Text] [Related]
8. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575 [TBL] [Abstract][Full Text] [Related]
9. New antipsychotic medications: what advantages do they offer? Citrome L Postgrad Med; 1997 Feb; 101(2):207-10, 213-4. PubMed ID: 9046936 [TBL] [Abstract][Full Text] [Related]
10. Early use of clozapine for poorly responding first-episode psychosis. Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221 [TBL] [Abstract][Full Text] [Related]
11. Risperidone versus other atypical antipsychotic medication for schizophrenia. Gilbody SM; Bagnall AM; Duggan L; Tuunainen A Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551 [TBL] [Abstract][Full Text] [Related]
12. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study. Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145 [TBL] [Abstract][Full Text] [Related]
14. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192 [TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
16. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Zimmet SV; Strous RD; Burgess ES; Kohnstamm S; Green AI J Clin Psychopharmacol; 2000 Feb; 20(1):94-8. PubMed ID: 10653215 [TBL] [Abstract][Full Text] [Related]
17. Clozapine levels and outcomes in Serbian patients with treatment-resistant psychotic disorders previously treated without measuring clozapine levels (CLOSER). de Haas HJ; Cohen D; de Koning MB; van Weringh G; Petrovic V; de Haan L; Touw DJ; Ignjatovic Ristic D Psychiatry Res; 2024 Sep; 339():116070. PubMed ID: 39029392 [TBL] [Abstract][Full Text] [Related]
18. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748 [TBL] [Abstract][Full Text] [Related]
19. Professional perception of clozapine use in patients with dual psychosis. Grau-López L; Szerman N; Torrens M; Basurte I; Vega P; Martínez-Raga J; Casas M; Roncero C Actas Esp Psiquiatr; 2020 May; 48(3):99-105. PubMed ID: 32905602 [TBL] [Abstract][Full Text] [Related]
20. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients. Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]